Chronic Cough Pathway
This appendix provides a structured clinical framework for the assessment and management of patients with chronic cough, adapted for use across South London respiratory services. It incorporates practical guidance on initial assessment, empirical treatment trials, escalation to advanced diagnostics, and referral for specialist input — including speech and language therapy and neuromodulator options.
For comprehensive national recommendations, refer to the latest:
British Thoracic Society (BTS) Clinical Statement on Chronic Cough in Adults (2023)
This guidance aligns closely with the multidisciplinary cough clinic pathway at King's College Hospital.

-
Initial Assessment:
-
Comprehensive clinical history and examination.
-
Baseline investigations: Chest X-ray, spirometry, FeNO.
2. Empirical Treatment Trials:
-
Postnasal drip: Antihistamines, nasal corticosteroids, saline douche.
-
Asthma/eosinophilic bronchitis: Trial of inhaled corticosteroids.
-
GERD: 8–12 weeks of PPI therapy and lifestyle advice.
3. Advanced Diagnostics:
-
HRCT chest if treatment response is poor.
-
Bronchoscopy if lesion suspected.
-
Consider ACE inhibitor use, smoking, chronic bronchitis.
4. Specialist Interventions:
-
Neuromodulators: e.g. Gabapentin, Amitriptyline.
-
Speech & Language Therapy for cough suppression.
5. Multidisciplinary Review:
-
Cases discussed in MDT with respiratory, speech therapy and specialist teams.
6. Research Trials:
-
Eligible patients may be offered enrolment in clinical studies (e.g. P2X3 antagonists like Gefapixant).